Patents. Law. Pharma.
917.609.2296
BLOG
Can Merck resurrect its $200M Sovaldi patent judgment against Gilead at the Supreme Court?
Merck ($MRK) lost a $200M patent judgment against Gilead ($GILD) after the Court found that Merck engaged in business and litigation misconduct. Merck is now appealing to the Supreme Court, asking to resurrect that judgment. Will it prevail?